Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 449

1.
2.

Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.

Conway GS, Clark PM, Wong D.

Clin Endocrinol (Oxf). 1993 Feb;38(2):219-22.

PMID:
8435903
3.

Beta-cell function and mass in type 2 diabetes.

Larsen MO.

Dan Med Bull. 2009 Aug;56(3):153-64.

PMID:
19728971
4.

Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.

Hamdi I, Green M, Shneerson JM, Palmer CR, Hales CN.

Clin Endocrinol (Oxf). 1993 Jul;39(1):21-6.

PMID:
8348704
5.

Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats.

Hoenig M, Jordan ET, Ferguson DC, de Vries F.

Domest Anim Endocrinol. 2010 Feb;38(2):95-102. doi: 10.1016/j.domaniend.2009.08.004. Epub 2009 Sep 17.

PMID:
19781890
6.
7.

Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism.

Chevenne D, Ruiz J, Lohmann L, Laudat A, Leblanc H, Gray IP, Passa P, Porquet D.

Clin Chem. 1994 May;40(5):754-7.

8.

Beta-cell function across the spectrum of glucose tolerance in obese youth.

Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R.

Diabetes. 2005 Jun;54(6):1735-43.

9.
10.

Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects.

Davis SN, Piatti PM, Monti L, Brown MD, Branch W, Hales CN, Alberti KG.

Metabolism. 1993 Jan;42(1):30-5.

PMID:
8446045
11.

Glucose tolerance and insulin response in normal-weight and obese cats.

Nelson RW, Himsel CA, Feldman EC, Bottoms GD.

Am J Vet Res. 1990 Sep;51(9):1357-62.

PMID:
2204297
12.

Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.

Pfützner A, Pfützner AH, Kann PH, Stute R, Löbig M, Yang JW, Mistry J, Forst T.

Clin Lab. 2005;51(5-6):243-9.

PMID:
15991797
13.

First direct assay for intact human proinsulin.

Houssa P, Dinesen B, Deberg M, Frank BH, Van Schravendijk C, Sodoyez-Goffaux F, Sodoyez JC.

Clin Chem. 1998 Jul;44(7):1514-9.

14.

Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function.

Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, Guthoff M, Silbernagel G, Stefan N, Häring HU, Fritsche A.

PLoS One. 2008;3(12):e3962. doi: 10.1371/journal.pone.0003962. Epub 2008 Dec 17.

15.

Effect of darglitazone on glucose clearance and lipid metabolism in obese cats.

Hoenig M, Ferguson DC.

Am J Vet Res. 2003 Nov;64(11):1409-13.

PMID:
14620778
16.

Development and validation of an enzyme-linked immunosorbent assay for feline trypsin-like immunoreactivity.

Steiner JM, Williams DA, Moeller EM, Melgarejo T.

Am J Vet Res. 2000 Jun;61(6):620-3.

PMID:
10850835
17.

[And what about diabetes?].

Cerasi E.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French.

PMID:
18225448
18.

Evaluation of routine hematology profile results and fructosamine, thyroxine, insulin, and proinsulin concentrations in lean, overweight, obese, and diabetic cats.

Hoenig M, Traas AM, Schaeffer DJ.

J Am Vet Med Assoc. 2013 Nov 1;243(9):1302-9. doi: 10.2460/javma.243.9.1302.

PMID:
24134581
19.

Effects of chromium supplementation on glucose tolerance in obese and nonobese cats.

Cohn LA, Dodam JR, McCaw DL, Tate DJ.

Am J Vet Res. 1999 Nov;60(11):1360-3.

PMID:
10566809
20.

Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat.

Zini E, Osto M, Franchini M, Guscetti F, Donath MY, Perren A, Heller RS, Linscheid P, Bouwman M, Ackermann M, Lutz TA, Reusch CE.

Diabetologia. 2009 Feb;52(2):336-46. doi: 10.1007/s00125-008-1201-y. Epub 2008 Nov 26.

PMID:
19034421

Supplemental Content

Support Center